alpha-2-adrenergic/I2-imidazoline receptor ligands (Rottapharm)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namealpha-2-adrenergic/I2-imidazoline receptor ligands (Rottapharm)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors alpha-2 modulatorsImidazoline I2 receptor modulators
TargetsImidazoline I2 receptorAdrenergic receptors alpha-2
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRottapharm Madaus Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRottapharm Madaus Gmbh
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A